| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |